The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Expanding the indication spectrum

Pulmonary arterial hypertension: pharmacologic therapies and potential pulmonary artery denervation treatment

EuroIntervention 2013;9:R149-R154. DOI: 10.4244/EIJV9SRA25

1. Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China;2. Department of Cardiology, Nanjing Heart Center, Nanjing, China

Pulmonary arterial hypertension (PAH) is a group of diseases related to progressively increasing pulmonary vascular resistance, a high incidence of right ventricular failure and premature death. Only a limited number of pharm

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article

Potential new indications and future studies